ClinicalTrials.gov · NCT06459310 · Recruiting
Pilot Study on Evaluating the Geroprotective Effect of Metformin
Registry record
NCT06459310 on ClinicalTrials.gov. The registry's last update to this record was 21 March 2025.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Pilot Study on Evaluating the Geroprotective Effect of Metformin Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor Xuanwu Hospital, Beijing Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Metformin Hydrochloride tablet; Placebo Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Composite the efficacy of metformin in intervening aging Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2025-03-21. Checked
Check history: NCT06459310 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: Xuanwu Hospital, Beijing
- Phase: Phase 2
- Status: Recruiting
- Intervention: Metformin Hydrochloride tablet; Placebo
- Primary outcome: Composite the efficacy of metformin in intervening aging
- Countries: China
- Start: 30 June 2024
- Completion (estimated): 31 July 2028
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.